Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
J Ren Nutr. 2010 Jul;20(4):243-54. doi: 10.1053/j.jrn.2009.10.006. Epub 2010 Mar 3.
Low serum parathyroid hormone (PTH) has been implicated as a primary biochemical marker of adynamic bone disease in individuals with chronic kidney disease (CKD) who undergo maintenance hemodialysis (MHD) treatment. We hypothesized that the malnutrition-inflammation complex is associated with low PTH levels in these patients and confounds the PTH-survival association.
We examined 748 stable MHD outpatients in southern California and followed them for up to 5 years (October 2001-December 2006).
In 748 MHD patients, serum PTH <150pg/mL was more prevalent among non-blacks and diabetics. There was no association between serum PTH and coronary artery calcification score, bone mineral density, or dietary protein or calorie intake. Low serum PTH was associated with markers of protein-energy wasting and inflammation, and this association confounded the relationship between serum PTH and alkaline phosphatase. Although 5-year crude mortality rates were similar across PTH increments, after adjustment for the case-mix and surrogates of malnutrition and inflammation, a moderately low serum PTH in 100-150pg/mL range was associated with the greatest survival compared to other serum PTH levels, i.e., a death hazard ratio of 0.52 (95% confidence interval: 0.29-0.92, p<0.001) compared to PTH of 300-600pg/mL (reference).
Low serum PTH may be another facet of the malnutrition-inflammation complex in CKD, and after controlling for this confounder, a moderately low PTH in 100-150pg/mL range appears associated with the greatest survival. Limitations of observational studies should be considered.
在接受维持性血液透析(MHD)治疗的慢性肾脏病(CKD)患者中,低血清甲状旁腺激素(PTH)被认为是骨动力障碍的主要生化标志物。我们假设营养不良-炎症综合征与这些患者的低 PTH 水平有关,并混淆了 PTH-生存关联。
我们检查了南加州 748 名稳定的 MHD 门诊患者,并对他们进行了长达 5 年的随访(2001 年 10 月至 2006 年 12 月)。
在 748 名 MHD 患者中,非黑人患者和糖尿病患者的血清 PTH<150pg/mL 更为常见。血清 PTH 与冠状动脉钙化评分、骨密度或饮食蛋白或热量摄入之间没有关联。低血清 PTH 与蛋白质-能量消耗和炎症标志物相关,这种关联混淆了血清 PTH 与碱性磷酸酶之间的关系。尽管 5 年的粗死亡率在各个 PTH 增量之间相似,但在调整病例组合以及营养不良和炎症的替代指标后,与其他血清 PTH 水平相比,100-150pg/mL 范围内的中度低血清 PTH 与最佳生存相关,即死亡风险比为 0.52(95%置信区间:0.29-0.92,p<0.001)与 300-600pg/mL 的 PTH(参考)相比。
低血清 PTH 可能是 CKD 中营养不良-炎症综合征的另一个方面,在控制这种混杂因素后,100-150pg/mL 范围内的中度低 PTH 似乎与最佳生存相关。应考虑观察性研究的局限性。